Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 138, Issue -, Pages S2-S3
Publisher
Elsevier BV
Online
2020-10-26
DOI
10.1016/s0959-8049(20)31078-9

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.